Modulation of the development of human monocyte-derived dendritic cells by lithium chloride

Area of Science:

• Immunology
• Neuroscience
• Pharmacology

Background:

• Lithium is explored for psychiatric and neurodegenerative diseases linked to immune dysfunction.
• Dendritic cells (DCs) are crucial regulators of immune responses.
• Understanding lithium's immunomodulatory effects on DCs is vital for its therapeutic applications.

Purpose of the Study:

• To investigate the impact of lithium chloride (LiCl) on the development and function of human monocyte-derived dendritic cells (iDCs).
• To elucidate the molecular signaling pathways mediating LiCl's effects on iDCs.

Main Methods:

• Human monocyte-derived iDCs were differentiated and/or matured in the presence of LiCl.
• Expression of DC maturation markers (CD86, CD83) and production of cytokines (IL-1β, IL-6, IL-8, IL-10, TNF-α) were analyzed.
• Intracellular signaling pathways including GSK-3β, PI3K, MEK, and PPARγ were investigated.

Main Results:

• LiCl exposure during iDC differentiation enhanced CD86 and CD83 expression and increased production of IL-1β, IL-6, IL-8, IL-10, and TNF-α.
• LiCl suppressed glycogen synthase kinase (GSK)-3β activity and activated PI3K, MEK, and peroxisome proliferator-activated receptor γ (PPARγ) during differentiation.
• LiCl modulated DC maturation markers and cytokine production via distinct pathways, with PPARγ downstream of GSK-3β.
• LiCl exhibited opposing effects on iDC maturation when present during LPS stimulation.

Conclusions:

• LiCl significantly influences iDC differentiation and function through modulation of multiple signaling pathways, including PI3K/AKT, MEK/ERK, GSK-3β, and PPARγ.
• These molecular mechanisms may contribute to the clinical efficacy of lithium in immune-related neurological and psychiatric disorders.
• Further research is warranted to fully understand the complex interplay of these pathways in vivo.